Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Environ Health Perspect ; 122(10): 1052-8, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24904982

RESUMO

BACKGROUND: Development of the epidermal permeability barrier (EPB) is essential for neonatal life. Defects in this barrier are found in many skin diseases such as atopic dermatitis. OBJECTIVE: We investigated the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the development and function of the EPB. METHODS: Timed-pregnant C57BL/6J mice were gavaged with corn oil or TCDD (10 µg/kg body weight) on gestation day 12. Embryos were harvested on embryonic day (E) 15, E16, E17, and postnatal day (PND) 1. RESULTS: A skin permeability assay showed that TCDD accelerated the development of the EPB, beginning at E15. This was accompanied by a significant decrease in transepidermal water loss (TEWL), enhanced stratification, and formation of the stratum corneum (SC). The levels of several ceramides were significantly increased at E15 and E16. PND1 histology revealed TCDD-induced acanthosis and epidermal hyperkeratosis. This was accompanied by disrupted epidermal tight junction (TJ) function, with increased dye leakage at the terminal claudin-1-staining TJs of the stratum granulosum. Because the animals did not have enhanced rates of TEWL, a commonly observed phenotype in animals with TJ defects, we performed tape-stripping. Removal of most of the SC resulted in a significant increase in TEWL in TCDD-exposed PND1 pups compared with their control group. CONCLUSIONS: These findings demonstrate that in utero exposure to TCDD accelerates the formation of an abnormal EPB with leaky TJs, warranting further study of environmental exposures, epithelial TJ integrity, and atopic disease.


Assuntos
Epiderme/efeitos dos fármacos , Substâncias Perigosas/toxicidade , Dibenzodioxinas Policloradas/toxicidade , Absorção Cutânea/efeitos dos fármacos , Junções Íntimas/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Epiderme/metabolismo , Feminino , Desenvolvimento Fetal/efeitos dos fármacos , Ceratose , Exposição Materna/efeitos adversos , Camundongos , Camundongos Endogâmicos C57BL , Permeabilidade/efeitos dos fármacos , Gravidez , Pele/metabolismo , Absorção Cutânea/fisiologia , Água/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA